A phase I dose escalation study of the tolerability of the...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

A phase I dose escalation study of the tolerability of the oral VEGFR and EGFR inhibitor vandetanib in combination with the oral MEK1/2 inhibitor selumetinib in solid tumors

Pacey, S., Blackhall, F., Garcia-Corbacho, J., Lipplaa, A., Fusi, A., Kumar, S., Hategan, M., Derham, J., Laviste, G., Halford, S., Foxton, C., McLeod, R., Wan, S., Talbot, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw383.61
Date:
October, 2016
File:
PDF, 38 KB
english, 2016
Conversion to is in progress
Conversion to is failed